SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 62 filers reported holding SPERO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,000 | +166.7% | 10,726 | +3475.3% | 0.00% | – |
| Q3 2020 | $3,000 | +200.0% | 300 | +200.0% | 0.00% | – |
| Q2 2020 | $1,000 | -83.3% | 100 | -85.7% | 0.00% | – |
| Q1 2020 | $6,000 | -33.3% | 700 | -22.2% | 0.00% | – |
| Q4 2019 | $9,000 | +28.6% | 900 | +28.6% | 0.00% | – |
| Q3 2019 | $7,000 | +16.7% | 700 | +40.0% | 0.00% | – |
| Q2 2019 | $6,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,376,968 | $13,247,000 | 23.08% |
| Aquilo Capital Management, LLC | 1,154,356 | $11,099,000 | 4.17% |
| VHCP Management II, LLC | 474,015 | $4,558,000 | 1.20% |
| AWM Investment Company, Inc. | 474,344 | $4,561,000 | 0.89% |
| Alphabet Inc. | 1,112,473 | $10,696,000 | 0.65% |
| BVF INC/IL | 845,405 | $8,129,000 | 0.62% |
| Novo Holdings A/S | 931,099 | $8,948,000 | 0.58% |
| Artal Group S.A. | 500,000 | $4,808,000 | 0.19% |
| Rock Springs Capital Management LP | 525,000 | $5,048,000 | 0.16% |
| Granahan Investment Management | 148,867 | $1,431,000 | 0.07% |